[GRAPHIC OMITTED]


John W. Hlywak, Jr. (Investors)               Jay Higham (Media/Physicians)
Senior Vice President and                     President and
Chief Financial Officer                       Chief Operating Officer
IntegraMed America, Inc.                      IntegraMed America, Inc.
(914) 251-4143                                (914) 251-4127
email:  jhlywak@integramed.com                email:  jhigham@integramed.com
        ----------------------                        ----------------------
Web Address:  http://www.integramed.com
              -------------------------

        INTEGRAMED AMERICA TO HOLD SECOND QUARTER 2005 FINANCIAL RESULTS
                         CONFERENCE CALL AUGUST 2, 2005

Purchase, NY, July 25, 2005 - IntegraMed America, Inc. (Nasdaq: INMD) today
announced that the Company will release second quarter 2005 financial results on
Monday, August 1, 2005, after the close of the financial markets. Gerardo Canet,
Chairman and Chief Executive Officer, Jay Higham, President and Chief Operating
Officer and John Hlywak, Senior Vice President and Chief Financial Officer, will
host an investment-community conference call beginning Tuesday, August 2, 2005,
at 10:00 a.m. Eastern Time to discuss those results and to answer questions.

To participate in the live call via telephone, please call (800) 374-0146
(domestic) or (706) 634-1307 (international). A telephone replay will be
available 12:00 p.m. Eastern Time, August 2 through August 9, 2005 by dialing
(800) 642-1687 (domestic) or (706) 645-9291 (international) and entering
reservation number 8143100.

Individuals interested in listening to the conference call via the Internet may
do so by visiting the Company's web site at www.integramed.com. A replay will be
available on the web site for 14 days.

IntegraMed America, based in Purchase, N.Y., is focused on the $2 billion
infertility industry, and offers products and services to patients and
providers. Specifically, the Company provides Business Services to a network of
Fertility Centers; distributes pharmaceutical products and financing programs
directly to patients; and operates www.integramed.com, an award-winning
infertility Web site.

Statements contained in this press release that are not based on historical
fact, including statements concerning future results, performance, expectations
and expansion of IntegraMed America are forward-looking statements that may
involve a number of risks and uncertainties. Actual results may differ
materially from the statements made as a result of various factors, including,
but not limited to, the risks associated with the Company's ability to finance
future growth; the loss of significant business service contract(s);
profitability at Reproductive Science Centers serviced by IntegraMed America;
changes in insurance coverage, government laws and regulations regarding health
care or managed care contracting; and other risks, including those identified in
the Company's most recent Form 10-K and in other documents filed by the Company
with the U.S. Securities and Exchange Commission. All information in this press
release is as of July 25, 2005 and IntegraMed undertakes no duty to update this
information.